Audeara Limited (ASX: AUA) has struck another high note with a US$917,000 (A$1.48 million) purchase order from Avedis Zildjian, one of the most revered names in the music industry. This follow-up order builds on an initial A$2.1 million order in February 2024, marking a continued partnership that bridges cutting-edge hearing technology with world-class musical craftsmanship.
With this second order, Audeara's innovative AUA Technology moves deeper into the mass production phase, reinforcing its commercial viability and scalability in global markets.
Dr. James Fielding, CEO and Founder of Audeara, expressed confidence in the partnership’s potential:
“This follow-up purchase order validates the commercial application of Audeara’s healthy hearing technology when incorporated into market-leading products with global commercial partners. With the recent momentum in our order pipeline, Audeara is demonstrating the potential of our AUA Technology division to scale across multiple addressable market segments.”
The deal follows other international partnerships, including a $570,000 order from Clinico Inc., Taiwan’s largest hearing aid retailer, for co-branded Clinico Sound Earbuds CS1.
The Avedis Zildjian Company, established in 1623 in the Ottoman Empire, is one of the oldest family-run businesses in the world. Founded by Armenian alchemist Avedis Zildjian, who discovered a secret alloy that produced extraordinary cymbals, the company has remained synonymous with premium percussion instruments.
Zildjian’s innovations have shaped the sound of modern music, from jazz to rock, with endorsements from legendary drummers like Buddy Rich, Ringo Starr, and Travis Barker. Despite its historic roots, Zildjian continues to push boundaries in manufacturing and technology, making its collaboration with Audeara a natural evolution.
The integration of Audeara’s hearing technology with Zildjian’s products reflects a broader industry trend: the fusion of music and hearing health.
For musicians, especially drummers, prolonged exposure to high-decibel sounds can lead to hearing damage. By embedding hearing-friendly technology in musical products, Audeara and Zildjian are addressing an often-overlooked issue—helping musicians preserve their most vital asset: their ears.
The benefits of this collaboration include:
✔ Enhanced sound clarity: Customised audio experiences for all users.
✔ Hearing health awareness: Protecting musicians from long-term damage.
✔ Market expansion: Tapping into a global audience of musicians and audiophiles.
The AUA Technology division is fast becoming the growth engine for Audeara. With minimal capital expenditure and a scalable licensing model, the company is transitioning from R&D to full-scale commercialisation.
The revenue from this latest purchase order will be recognised upon shipment, but the timing of future orders will depend on market demand. Given the traction Audeara has built, the potential for continued collaboration with Zildjian remains strong.
With this latest order, Audeara continues to fine-tune its strategy for international expansion. The company’s push into global markets—spanning music, audiology, and hearing technology—positions it as a key player in the intersection of health and sound innovation.
As musicians and consumers become more aware of hearing health, partnerships like this could redefine industry standards. In the words of Zildjian’s founder, Avedis I:
“May your cymbals sound for eternity.”
With Audeara’s technology, those cymbals—and the ears that hear them—might just last a little longer.